ImmunologybioRxiv
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant
V.-V. Edara, K. E. Manning, M. Ellis…·M. S. Suthar
This study evaluates the neutralizing activity of mRNA vaccines against the SARS-CoV-2 Omicron variant, showing reduced efficacy after the second dose but improved responses following a third dose.
DOI 10.1016/j.xcrm.2022.100529